Company Overview and News

1
Nikkei hits 3-mth high on solid earnings, Wall St surge; Suzuki, Panasonic shine

2018-05-11 reuters
TOKYO, May 11 (Reuters) - Japan’s Nikkei share average rose to a three-month high on Friday, buoyed by tepid U.S. inflation data easing concerns over the Federal Reserve hiking rates at an accelerated pace, as well on gains for several companies posting solid earnings.

 
Nikkei hits 3-month high; Suzuki, Panasonic shine

2018-05-11 thehindubusinessline
anasonic Corp gained 4.7 per cent after the electronics conglomerate reported a 58 per cent surge in net profit for the year ended March to ¥236.04 billion.

 
Nikkei hits 3-month highs after Wall St rally; Suzuki, Panasonic shine

2018-05-11 reuters
TOKYO, May 11 (Reuters) - Japan’s Nikkei share average rose to three-month highs on Friday, buoyed by a surge on Wall Street after weaker-than-expected U.S. inflation data eased concerns over the Federal Reserve hiking interest rates at an accelerated pace.

 
Nikkei edges lower on firm yen

2018-05-07 japantimes.co.jp
The benchmark Nikkei average slightly fell on the Tokyo Stock Exchange Monday, hit by the yen’s strength against the dollar.

 
Tokyo stocks turn easier ahead of four-day holiday

2018-05-02 japantimes.co.jp
Stocks turned lower on the Tokyo Stock Exchange on Wednesday, weighed down by profit-taking as investors refrained from active buying ahead of a four-day holiday in Japan.

 
Japan's Nikkei slips ahead of Fed; automakers, Fujifilm retreat

2018-05-02 reuters
TOKYO, May 2 (Reuters) - Japan’s Nikkei share average slipped on Wednesday amid caution ahead of the Federal Reserve’s policy decision and U.S. jobs data, although the dollar’s rise against the yen and positive sentiment toward tech stocks helped curb some of the losses.

 
Nikkei sags as automakers slip on softer US sales

2018-05-02 thehindubusinessline
Japan's Nikkei share average dipped on Wednesday, weighed by weaker automakers, although the dollar's rise to three-month highs versus the yen and positive sentiment toward tech stocks helped curb some of the losses.

 
Japan's Nikkei sags as automakers slip on softer U.S. sales

2018-05-02 reuters
TOKYO, May 2 (Reuters) - Japan’s Nikkei share average dipped on Wednesday, weighed by weaker automakers, although the dollar’s rise to three-month highs versus the yen and positive sentiment toward tech stocks helped curb some of the losses.

 
Nikkei edges lower as index-heavy stocks weaken

2018-04-23 thehindubusinessline
Medical equipment maker Terumo Corp stumbled 3.4 per cent and SoftBank shed 1.0 per cent, collectively knocking 25 points off the Nikkei. - REUTERS

 
Nikkei edges lower as tech sector sell-off weighs

2018-04-20 reuters
TOKYO, April 20 (Reuters) - Japan’s Nikkei share average edged lower on Friday morning as worries about slower smartphone demand hit technology shares, while financial stocks rallied thanks to higher U.S. yields.

 
Nikkei flat as tech sector losses offset financials rally

2018-04-20 reuters
TOKYO, April 20 (Reuters) - Japan’s Nikkei share average was flat in choppy trade on Friday morning as worries about slower smartphone demand hit technology shares, while financial stocks rallied helped by higher U.S. yields.

 
Nikkei drops to 6-month low on global trade worries

2018-03-26 thehindubusinessline
Japan's Nikkei share average dropped to a six-month low on Monday morning while the yen rose to near a 16-month peak, on persistent worries about a global trade war, although some stocks were in demand before they go ex-dividend this week.

 
Nikkei drops to 6-month low on global trade worries

2018-03-26 reuters
TOKYO, March 26 (Reuters) - Japan’s Nikkei share average dropped to a six-month low on Monday morning while the yen rose to near a 16-month peak, on persistent worries about a global trade war, although some stocks were in demand before they go ex-dividend this week.

 
Tokyo stocks slip further on Abe’s falling popularity

2018-03-19 japantimes.co.jp
Stocks lost further ground on the Tokyo Stock Exchange on Monday after public support rates for the administration of Prime Minister Shinzo Abe tumbled due to a cronyism scandal.

 
Tokyo stocks turn lower on yen’s firmness

2018-03-16 japantimes.co.jp
Stocks turned lower on the Tokyo Stock Exchange on Friday, hurt by the yen’s rise against the dollar.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 006610403